21 CFR 520.1408

§ 520.1408 Methylprednisolone.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 520.1408, § 520.1408 Methylprednisolone, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87226
Permanent ID: ys:prov:87226@1
SHA-256: 5e7c2c0b80553076cdf9ae430e7e52031cefd346ddc8e855a4e3464f713892ab

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each tablet contains 1, 2, or 4 milligrams (mg) of methylprednisolone. (b) Sponsors. See Nos. 054771 and 069043 in § 510.600(c) of this chapter. (c) Conditions of use in dogs and cats—(1) Amount. 5 to 15 pounds (lbs): 2 mg; 15 to 40 lbs: 2 to 4 mg; 40 to 80 lbs: 4 to 8 mg. Administer total daily dose orally in equally divided doses 6 to 10 hours apart until response is noted or 7 days have elapsed. (2) Indications for use. As an anti-inflammatory agent. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.